Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals

Clin Infect Dis. 1998 Oct;27(4):901-2. doi: 10.1086/517165.

Authors

E Tacconelli¹, M Tumbarello, K de Gaetano, R Cauda, L Ortona

Affiliation

¹ Department of Infection Diseases, Catholic University, Roma, Italy.

PMID: 9798056
DOI: 10.1086/517165

No abstract available

MeSH terms

AIDS-Related Opportunistic Infections / epidemiology*
AIDS-Related Opportunistic Infections / immunology
Anti-HIV Agents / therapeutic use*
Bacteremia / epidemiology*
Bacteremia / immunology
Case-Control Studies
Drug Therapy, Combination
Female
HIV Protease Inhibitors / therapeutic use*
Humans
Incidence
Male
Prospective Studies
Reverse Transcriptase Inhibitors / therapeutic use*
Risk-Taking

Substances

Anti-HIV Agents
HIV Protease Inhibitors
Reverse Transcriptase Inhibitors